(Q85926737)

English

Measurement of dabigatran and rivaroxaban in primary prevention of venous thromboembolism in 106 patients, who have undergone major orthopedic surgery: an observational study

scientific article published on 01 February 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23335022%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Measurement of dabigatran and rivaroxaban in primary prevention of venous thromboembolism in 106 patients, who have undergone major orthopedic surgery: an observational study (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23335022%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

1 reference

based on heuristic

inferred from title

venous thromboembolism

1 reference

based on heuristic

inferred from title

author name string

Meyer Michel Samama

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23335022%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Céline Guinet

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23335022%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Léna Le Flem

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23335022%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Emmanuel Ninin

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23335022%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Jean-Marc Debue

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23335022%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

publication date

1 February 2013

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23335022%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Journal of Thrombosis and Thrombolysis

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23335022%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

35

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23335022%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23335022%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

140-146

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23335022%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

https://scigraph.springernature.com/pub.10.1007/s11239-012-0803-x

0 references

The frequency of prescription of P-glycoprotein-affecting drugs in atrial fibrillation

1 reference

https://pubmed.ncbi.nlm.nih.gov/23335022

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rivaroxaban differentially influences ex vivo global coagulation assays based on the administration time

1 reference

https://pubmed.ncbi.nlm.nih.gov/23335022

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rivaroxaban: population pharmacokinetic analyses in patients treated for acute deep-vein thrombosis and exposure simulations in patients with atrial fibrillation treated for stroke prevention

1 reference

https://pubmed.ncbi.nlm.nih.gov/23335022

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The International Normalized Ratio calibrated for rivaroxaban has the potential to normalize prothrombin time results for rivaroxaban-treated patients: results of an in vitro study.

1 reference

https://pubmed.ncbi.nlm.nih.gov/23335022

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Assessment of laboratory assays to measure rivaroxaban--an oral, direct factor Xa inhibitor.

1 reference

https://pubmed.ncbi.nlm.nih.gov/23335022

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

An optimised, rapid chromogenic assay, specific for measuring direct factor Xa inhibitors (rivaroxaban) in plasma

1 reference

https://pubmed.ncbi.nlm.nih.gov/23335022

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dabigatran etexilate--a novel, reversible, oral direct thrombin inhibitor: interpretation of coagulation assays and reversal of anticoagulant activity

1 reference

https://pubmed.ncbi.nlm.nih.gov/23335022

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Impact of dabigatran on a large panel of routine or specific coagulation assays. Laboratory recommendations for monitoring of dabigatran etexilate

1 reference

https://pubmed.ncbi.nlm.nih.gov/23335022

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The paradoxical stimulation by a reversible thrombin inhibitor of thrombin generation in plasma measured with thrombinography is caused by alpha-macroglobulin-thrombin.

1 reference

https://pubmed.ncbi.nlm.nih.gov/23335022

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Three different patterns of calibrated automated thrombogram obtained with six different anticoagulants

1 reference

https://pubmed.ncbi.nlm.nih.gov/23335022

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evaluation of the prothrombin time for measuring rivaroxaban plasma concentrations using calibrators and controls: results of a multicenter field trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/23335022

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rivaroxaban-once daily, oral, direct factor Xa inhibition compared with vitamin K antagonism for prevention of stroke and Embolism Trial in Atrial Fibrillation: rationale and design of the ROCKET AF study

1 reference

https://pubmed.ncbi.nlm.nih.gov/23335022

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetics and pharmacodynamics of the direct oral thrombin inhibitor dabigatran in healthy elderly subjects

1 reference

https://pubmed.ncbi.nlm.nih.gov/23335022

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Life-threatening bleeding in four patients with an unusual excessive response to dabigatran: implications for emergency surgery and resuscitation

1 reference

https://pubmed.ncbi.nlm.nih.gov/23335022

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The use of dabigatran in elderly patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/23335022

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dabigatran versus warfarin in patients with atrial fibrillation

1 reference

https://pubmed.ncbi.nlm.nih.gov/23335022

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Coagulation parameters in patients receiving dabigatran etexilate or rivaroxaban: two observational studies in patients undergoing total hip or total knee replacement

1 reference

https://pubmed.ncbi.nlm.nih.gov/23335022

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evaluation of the anti-factor Xa chromogenic assay for the measurement of rivaroxaban plasma concentrations using calibrators and controls

1 reference

https://pubmed.ncbi.nlm.nih.gov/23335022

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dabigatran etexilate for stroke prevention in patients with atrial fibrillation: resolving uncertainties in routine practice

1 reference

https://pubmed.ncbi.nlm.nih.gov/23335022

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Population pharmacokinetics and pharmacodynamics of once- and twice-daily rivaroxaban for the prevention of venous thromboembolism in patients undergoing total hip replacement

1 reference

https://pubmed.ncbi.nlm.nih.gov/23335022

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q85926737&oldid=1758231896"